Recommendations for weaning off cardiopulmonary support in children with fulminant myocarditis

被引:2
作者
Kanamaru, Hiroshi [1 ]
Karasawa, Kensuke [1 ]
Abe, Osamu [1 ]
Miyashita, Michio [1 ]
Ayusawa, Mamoru [1 ]
Sumitomo, Naokata [1 ]
Okada, Tomoo [1 ]
Harada, Kensuke [1 ]
Mugishima, Hideo [1 ]
机构
[1] Nihon Univ, Dept Pediat & Childhlth, Sch Med, Itabashi Ku, Tokyo 1738610, Japan
关键词
cardiopulmonary support; creatine kinase; disseminated intravascular coagulation; fulminant; myocarditis; mixed venous blood oxygen saturation;
D O I
10.1253/circj.71.1551
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The purpose of this study was to determine the appropriate recommendations for weaning off cardiopulmonary support (CPS) in children with fulminant myocarditis. Methods and Results Four consecutive patients diagnosed with fulminant myocarditis who were treated with CPS were enrolled (mean age: 9 years). The relationships between timing of weaning from CPS and various factors, including bleeding episodes, platelet count, serum concentration of the MB isoform of creatine kinase (CK-MB), echocardiographic findings, and the mixed venous blood oxygen saturation (SvO(2)), were retrospectively analyzed. All patients had CPS performed safely for a mean duration of 53.1 h without exchange of the circuit. Three of the 4 patients had a bleeding episode before discontinuation. The minimum platelet count occurred during weaning in all 4 patients. The peak serum CK-MB concentration when initiating CPS was higher than the peak value on the day of weaning. Echocardiographic findings before stopping CPS were similar to those after weaning. The SvO(2) was 62.5% when initiating CPS and 71.3% before weaning. Conclusions In children with fulminant myocarditis CPS can be used without exchanging the circuit and can be discontinued before bleeding episodes become symptomatic, with improvement in the biomarkers and SvO(2) on weaning off CPS.
引用
收藏
页码:1551 / 1554
页数:4
相关论文
共 14 条
[1]   National survey of fulminant myocarditis in Japan - Therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee) [J].
Aoyama, N ;
Izumi, T ;
Hiramori, K ;
Isobe, M ;
Kawana, M ;
Hiroe, M ;
Hishida, H ;
Kitaura, Y ;
Imaizumi, T .
CIRCULATION JOURNAL, 2002, 66 (02) :133-144
[2]   Idiopathic giant-cell myocarditis - Natural history and treatment [J].
Cooper, LT ;
Berry, GJ ;
Shabetai, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1860-1866
[3]   ACTIVE MYOCARDITIS IN THE SPECTRUM OF ACUTE DILATED CARDIOMYOPATHIES - CLINICAL-FEATURES, HISTOLOGIC CORRELATES, AND CLINICAL OUTCOME [J].
DEC, GW ;
PALACIOS, IF ;
FALLON, JT ;
ARETZ, HT ;
MILLS, J ;
LEE, DCS ;
JOHNSON, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (14) :885-890
[4]   DIAGNOSIS AND CLASSIFICATION OF MYOCARDITIS BY ENDOMYOCARDIAL BIOPSY [J].
FENOGLIO, JJ ;
URSELL, PC ;
KELLOGG, CF ;
DRUSIN, RE ;
WEISS, MB .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (01) :12-18
[5]  
GREASON KL, 1995, ANN THORAC SURG, V60, P209
[6]   Transient ventricular wall thickening in acute myocarditis - A serial echocardiographic and histopathologic study [J].
Hiramitsu, S ;
Morimoto, S ;
Kato, S ;
Uemura, A ;
Kubo, N ;
Kimura, K ;
Sugiura, A ;
Itoh, T ;
Hishida, H .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2001, 65 (10) :863-866
[7]   Rescue of a child with fulminant myocarditis using percutaneous cardiopulmonary support [J].
Inoue, Y ;
Kaneko, H ;
Yoshizawa, Y ;
Morikawa, A .
PEDIATRIC CARDIOLOGY, 2000, 21 (02) :158-160
[8]   Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change [J].
Kishimoto, C ;
Takamatsu, N ;
Kawamata, H ;
Shinohara, H ;
Ochiai, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (06) :1979-1984
[9]   Cardiac troponin T in patients with clinically suspected myocarditis [J].
Lauer, B ;
Niederau, C ;
Kuhl, U ;
Schannwell, M ;
Pauschinger, M ;
Strauer, BE ;
Schultheiss, HP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (05) :1354-1359
[10]   A CLINICAL-TRIAL OF IMMUNOSUPPRESSIVE THERAPY FOR MYOCARDITIS [J].
MASON, JW ;
OCONNELL, JB ;
HERSKOWITZ, A ;
ROSE, NR ;
MCMANUS, BM ;
BILLINGHAM, ME ;
MOON, TE ;
COSTANZO, MR ;
GRADY, K ;
KANTROWITZ, NE ;
ZELDIS, SM ;
KANE, S ;
COGLIANESE, ME ;
TOMEO, C ;
BACON, K ;
MCLAUGHLIN, PR ;
LIU, P ;
ROSS, B ;
PALACIOS, IF ;
DEC, W ;
BLOCK, B ;
COCCASPOFFARD, D ;
YOUNG, JB ;
LEON, C ;
CASTA, R ;
KINGRY, C ;
STRICKMAN, NE ;
HARLAN, M ;
FOWLER, N ;
ENGEL, P ;
NUNN, N ;
DAS, SK ;
SUHY, P ;
KLINE, E ;
GILLES, AJ ;
FRENCH, WJ ;
SKINNER, A ;
UNVERFERTH, DV ;
SARLING, R ;
NEWTON, P ;
WOODINGSCOTT, M ;
UNTEREKER, WJ ;
POLL, D ;
HOFFMAN, K ;
FRANK, J ;
FOWLES, R ;
MILLAR, K ;
FREEDMAN, L ;
LYVER, S ;
LATHAM, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :269-275